Prosecution Insights
Last updated: October 04, 2026

Inskeep Intellectual Property Group, Inc.

Technology area: Medical Devices & Mechanical Engineering

40 pending office actions • 19 clients • 37 examiners • 12 art units • 0 of 40 (0%) have an AI response strategy ready

Analysis

INSKEEP INTELLECTUAL PROPERTY GROUP, INC specializes in the Medical Devices & Mechanical Engineering technology area. The firm has managed 2089 career applications, demonstrating a strong history of handling engineering and medical patent filings. Its resolved allowance rate pct of 82.14 indicates a high frequency of successful outcomes for its clients. This metric underscores the firm's proficiency in securing intellectual property in these engineering sectors.

Currently, the firm is managing 33 pending office actions, representing its active workload before the patent office. The firm averages 4.33 avg office actions per allowance, reflecting a rigorous examination process that often requires multiple responses to the patent office. For practitioners, the 82.14 resolved allowance rate pct and 4.33 avg office actions per allowance serve as key metrics for evaluating the firm's prosecution strategy and persistence across its 2089 career applications. These data points help set realistic expectations for the prosecution cycle in Medical Devices & Mechanical Engineering.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=2089 apps, methodology: how we score firms)

82.1%
Allowance Rate
n=2089
+0.56σ
Allowance Rate (norm)
n=2089
4.3
OAs to Allowance
n=1035
+0.30σ
OAs to Allow (norm)
n=1035
1206 days
Time to Allowance
n=1035
+14.0pp
Interview Lift
n=2089
36.5%
RCE Rate
n=2089
1.8%
Appeal Rate
n=2089

Rejection Performance (% of received rejections ultimately overcome)

79.1%
§101 Overcome
n=91
79.6%
§102 Overcome
n=616
80.8%
§103 Overcome
n=845
83.5%
§112 Overcome
n=612

Specialization & Scale

A61B, A61F, A61M
Top CPC Subclasses
40%
Top-3 CPC Share
n=2089
2
Practitioners
n=2089
1044.5
Apps / Practitioner
n=2089

Portfolio Summary

40
Total Pending OAs
23
Non-Final OAs
14
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
3
Due this month
3
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (3)Due ≤ 60 days (3)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

16
Hard (40%)
23
Medium (58%)
1
Easy (2%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only18 (45%)
§102 only1 (2%)
§112 only1 (2%)
Double-patenting + other4 (10%)
Multi-statute (no §101)16 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
2% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
2% of docket
30
Mechanical / Eng
75% of docket
8
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

400 h
Manual time on pending OAs
80 h
Time saved (low, 20%)
140 h
Time saved (mid, 35%)
3.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YABUT, DIANE D 2 62.5% +27.9%
SHI, KATHERINE MENGLIN 2 78.4% +21.7%
MATHEW, SEEMA 2 71.4% +26.1%
GHAND, JENNIFER LEIGH-STEWAR 1 60.5% +27.8%
FISHBACK, ASHLEY LAUREN 1 80.1% +21.9%
HUPCZEY, JR, RONALD JAMES 1 64.7% +22.6%
JAHAN, ISRAT 1 — —
KOWALKOWSKI, FIONA MARGARET 1 100.0% +0.0%
CHRISTIANSON, SKYLAR LINDSEY 1 59.6% +27.7%
CHOUDHURY, MUSTAK 1 84.9% +21.2%

Hard Cases (16)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17815549 Apparatus And Method For Contacting Blood With Ozone MELLON, DAVID C 321d overdue
18871418 Vascular Occlusion Device FISHBACK, ASHLEY LAUREN 16d overdue
18679427 ROTARY INSTRUMENTS AND METHODS FOR INTRAUTERINE TISSUE RESECTION LONG, SARAH A 15d
17810241 Midline Marker For Sling Implant PENG, BO JOSEPH 33d
18692118 ASPIRATION THROMBECTOMY SYSTEM LEVY, BRANDON WILLIAM 83d
18894920 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE JAHAN, ISRAT —
18894577 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE KOWALKOWSKI, FIONA MARGARET —
18894729 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE CHRISTIANSON, SKYLAR LINDSEY —

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18871418 Vascular Occlusion Device FISHBACK, ASHLEY LAUREN 16d overdue
18795018 Method And Apparatus For Stent Delivery SHI, KATHERINE MENGLIN 15d
19174781 Asymmetric Occluder Device YABUT, DIANE D —
19171056 Occlusion Systems SHI, KATHERINE MENGLIN —
19045628 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE GHAND, JENNIFER LEIGH-STEWAR —
18859956 HEART VALVE LEAFLET MODIFICATION HUPCZEY, JR, RONALD JAMES —
18894729 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE CHRISTIANSON, SKYLAR LINDSEY —
18893680 INDIUM TIN OXIDE REFLECTION CONTROL CHOUDHURY, MUSTAK —

Client Portfolio (19 clients)

Top Art Units

Art UnitApps
377113
37945
37743
37922
37812
28721
37251
37521
37831
37321

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19174781 Asymmetric Occluder Device Occlutech GmbH YABUT, DIANE D §102§103§112DP Non-Final OA — Pending Apr 09, 2025
19171056 Occlusion Systems Terumo Corporation SHI, KATHERINE MENGLIN §102§103DP Non-Final OA — Pending Apr 04, 2025
19045628 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE BOSTON SCIENTIFIC CORPORATION GHAND, JENNIFER LEIGH-STEWAR §112DP Non-Final OA — Pending Feb 05, 2025
18871418 Vascular Occlusion Device Terumo Corporation FISHBACK, ASHLEY LAUREN 3771 §102§103 Final Rejection 16d overdue Pending Dec 03, 2024
18859956 HEART VALVE LEAFLET MODIFICATION Amx Technologies, LLC HUPCZEY, JR, RONALD JAMES 3794 §112Other Non-Final OA — Pending Oct 24, 2024
18894920 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE BOSTON SCIENTIFIC CORPORATION JAHAN, ISRAT §103§112 Non-Final OA — Pending Sep 24, 2024
18894577 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE BOSTON SCIENTIFIC CORPORATION KOWALKOWSKI, FIONA MARGARET 3792 §103§112 Non-Final OA — Pending Sep 24, 2024
18894729 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE BOSTON SCIENTIFIC CORPORATION CHRISTIANSON, SKYLAR LINDSEY 3792 §102§103§112 Non-Final OA — Pending Sep 24, 2024
18893680 INDIUM TIN OXIDE REFLECTION CONTROL Hoya Optical Labs Of America, Inc. CHOUDHURY, MUSTAK §102§103 Non-Final OA — Pending Sep 23, 2024
18887772 IMPLANT DELIVERY SYSTEM Microvention, Inc. HOLWERDA, KATHLEEN SONNETT 3771 §102§103 Non-Final OA — Pending Sep 17, 2024
18801382 INTRODUCER SYSTEM WITH INFLATABLE VALVE Echo Medical, LLC DESANTO, MATTHEW F §102§103 Non-Final OA — Pending Aug 12, 2024
18797309 Implant, Medical Implant, And Method For Delivery Of A Medical Implant Maslanka Patentverwaltung GmbH MATHEW, SEEMA 3774 §103 Final Rejection — Pending Aug 07, 2024
18795018 Method And Apparatus For Stent Delivery Microvention, Inc. SHI, KATHERINE MENGLIN 3771 §102 Final Rejection 15d Pending Aug 05, 2024
18777366 Annuloplasty Ring For Receiving A Replacement Valve Northwestern University MATHEW, SEEMA §103Other Non-Final OA — Pending Jul 18, 2024
18727061 METHODS AND DEVICES FOR REMOVING HEART VALVE THERAPY Amx Technologies, LLC FOWLER, DANIEL WAYNE 3794 §103 Final Rejection — Pending Jul 05, 2024
18715104 SLOW LIGHT AMPLIFIER AND METHODOLOGY FOR IMPROVING SIGNAL STRENGTH IN ACOUSTO-OPTICAL TOMOGRAPHY Deep Light Vision AB NGUYEN, RACHEL NICOLE §102§103§112 Non-Final OA — Pending May 30, 2024
18679427 ROTARY INSTRUMENTS AND METHODS FOR INTRAUTERINE TISSUE RESECTION Caldera Medical, Inc. LONG, SARAH A 3771 §102§103 Final Rejection 15d Pending May 30, 2024
18658423 Occlusion Systems Terumo Corporation LE, KHOA TAN 3771 §103 Final Rejection — Pending May 08, 2024
18699153 WIRE GRID POLARIZER REFLECTION CONTROL WITH COLORED FILMS Hoya Optical Labs Of America, Inc. DABBI, JYOTSNA V 2872 §103 Non-Final OA — Pending Apr 05, 2024
18620792 METHOD OF MANUFACTURING A PAN AND NON-STICK PAN Jiangmen Bonanza Metalware Co., Ltd. BROWN, JARED O 3725 §103 Final Rejection 33d Pending Mar 28, 2024
18692118 ASPIRATION THROMBECTOMY SYSTEM Microvention, Inc. LEVY, BRANDON WILLIAM 3781 §103§112 Non-Final OA 83d Pending Mar 14, 2024
18603899 PROSTHETIC HEART VALVES The Global Heart Valve Innovation Center (Israel) Ltd. COCHRAN, KARI LEE 3774 §103 Non-Final OA — Pending Mar 13, 2024
18436487 Releasable Delivery System Microvention, Inc. RIVERS, LINDSEY RAE 3771 §102§103§112 Non-Final OA — Pending Feb 08, 2024
18576356 STRETCH RESISTANT EMBOLIC COIL Microvention, Inc. NEMER, OSAMA MOHAMMAD 3771 §103 Final Rejection 41d Pending Jan 03, 2024
18398003 Left Atrial Appendage Stasis Reduction Nidus Biomedical, LLC WIEST, PHILIP R 3781 §102§103DP Non-Final OA — Pending Dec 27, 2023
18390337 Battery Extinguishing Device Firekim Energy Solution Co., Ltd. SUTHERLAND, STEVEN M 3752 §103 Non-Final OA 17d overdue Pending Dec 20, 2023
18525657 Inner Support Catheter Microvention, Inc. AHMED, TASNIM M 3783 §102§103 Final Rejection — Pending Nov 30, 2023
18561684 Vascular Prosthesis With Drawn Filled Tubes Microvention, Inc. EREZO, DARWIN P 3771 §103 Final Rejection 22d Pending Nov 16, 2023
18338587 Stent Delivery System And Method Microvention, Inc. RESTAINO, ANDREW PETER 3771 §103 Final Rejection — Pending Jun 21, 2023
18315405 Vascular Medical Device, System And Method Swiss Capital -- Engineering AG LAUER, CHRISTINA C 3771 §103 Final Rejection — Pending May 10, 2023
18303469 Waterproof Shoe And Manufacturing Method For The Waterproof Shoe Foshan Chenxi Textile Co., Ltd. COLLIER, JAMESON D 3732 §103 Non-Final OA 134d overdue Pending Apr 19, 2023
18044761 Method And Device For Removing Heart Valve Therapy Amx Technologies, LLC BOCK, ABIGAIL MARIE 3794 §103 Non-Final OA 9d overdue Pending Mar 09, 2023
17815549 Apparatus And Method For Contacting Blood With Ozone Sangair AB MELLON, DAVID C 1779 §102§103 Non-Final OA 321d overdue Pending Jul 27, 2022
17810241 Midline Marker For Sling Implant Caldera Medical, Inc. PENG, BO JOSEPH 3797 §102§103§112 Non-Final OA 33d Pending Jun 30, 2022
17805640 Hemostatic Device For A Heart Syntach AG YABUT, DIANE D 3771 §103 Final Rejection — Pending Jun 06, 2022
17775622 DEVICE AND METHOD FOR CEREBRAL TEMPERATURE CONTROL Teqcool AB PAPE, ALYSSA MORGAN 3794 §103 Non-Final OA — Pending May 10, 2022
17755614 Methods And Apparatus For Heart Valve Leaflet Modification Amx Technologies, LLC TEMPLETON, MARINA DELANEY 3794 §102§103 Non-Final OA — Pending May 03, 2022
17455648 FUSIFORM ANEURYSM TREATMENT Microvention, Inc. MCEVOY, THOMAS M 3771 §102§103§112 Non-Final OA — Pending Nov 18, 2021
17499711 Pulmonary Embolism Removal System Terumo Corporation DUBOSE, LAUREN 3771 §103 Non-Final OA 112d overdue Pending Oct 12, 2021
16685995 Radiopaque Vascular Prosthesis Microvention, Inc. PRONE, CHRISTOPHER D 3774 §103 Final Rejection 71d overdue Pending Nov 15, 2019

Managing Inskeep Intellectual Property Group, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month